Post Profile






GOOD: New Drug for Severe Eczema Is Successful in 2 New Trials. “Most patients who got the active …

GOOD: New Drug for Severe Eczema Is Successful in 2 New Trials. “Most patients who got the active drug, dupilumab, instead of a placebo reported that the itching began to wane within two weeks and was gone in a few months, as their skin began to clear. Nearly 40 percent of participants getting the drug […]
read more

share

Related Posts


Sanofi may win U.S. approval of $3 billion eczema drug by March

Health : Reuters: Health

(Reuters) - French drugmaker Sanofi  and its U.S. partner Regeneron Pharmaceuticals could win U.S. approval for their keenly awaited new eczema drug dupilumab, seen by analysts as a potential $3 billion-a-year seller, by next March.

Medical News Today: Eczema successfully treated with arthritis drug

Health : Medical News Today

Researchers describe how an approved arthritis drug successfully treated 6 patients with moderate to severe eczema that was not responding to conventional treatments.

J&J psoriasis drug tops placebo, Humira in late stage study

Health : Reuters: Health

(Reuters) - An experimental biotech drug developed by Johnson & Johnson proved more effective at clearing moderate to severe cases of the skin condition plaque psoriasis than a placebo or Abbvie Inc's big-selling Humira, according t...

Studying The Placebo Effect In Asthma Patients Receiving Bronchodilator Treatment vs Placebo Treatments vs. No Treatment At All

Health : Medical News Today

Placebos are "dummy pills" often used in research trials to test new drug therapies and the "placebo effect" is the benefit patients receive from a treatment that has no active ingredients. Many claim that the placebo effect is a cr...

New Drug for Severe Eczema Is Successful in 2 New Trials

Health : NYTimes: Health

Atopic dermatitis causes itching so extreme that many patients consider suicide. In trials, most patients said symptoms waned in the first two weeks of taking a new drug.

Comments


Copyright © 2016 Regator, LLC